Tag: Bevacizumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Bevacizumab

Sutro Biopharma Presents Data from Dose-Optimization - GlobeNewswire

Added to Collection on: 2025-03-15 22:50:58

Tags for this article:

Sutro Biopharma
Biotechnology
Antibody-drug conjugate
Bevacizumab
Cancer
Ovarian cancer
Sutro Biopharma Inc

Click the tags to see associated articles and topics

View Article Details
Tempest Reports Year End 2024 Financial Results and Provides Business Update

Added to Collection on: 2025-03-27 20:23:21

Tags for this article:

Orphan drugs
Atezolizumab
Roche
Bevacizumab
Hepatocellular carcinoma
Tempest Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Glioblastoma Market: Epidemiology, Therapies, Companies, DelveInsight - openPR.com

Added to Collection on: 2025-05-01 18:16:04

Tags for this article:

Brain tumor
Cancer
Glioblastoma
Oncology
Bevacizumab
Glioblast
Epitopoietic Research Corporation
GBM

Click the tags to see associated articles and topics

View Article Details
Biosimilar Monoclonal Antibodies Market Know the Scope and Trends - openPR.com

Added to Collection on: 2025-05-16 14:59:59

Tags for this article:

Monoclonal antibodies
Orphan drugs
Specialty drugs
Immunosuppressants
Immunology
Biosimilar
Adalimumab
Biopharmaceutical
Infliximab
Rituximab
Trastuzumab
Bevacizumab
Denosumab
Cetuximab
Ranibizumab
Eculizumab

Click the tags to see associated articles and topics

View Article Details
Global Scandal: The Dangerous Trade in Fake Cancer Drugs - OncoDaily

Added to Collection on: 2025-07-13 19:41:43

Tags for this article:

Pharmaceuticals policy
Cancer
Online pharmacies
Counterfeit medications
Oncology
Bevacizumab
Cancer treatment
Counterfeit consumer good
Breast cancer
Chemotherapy
Medication
Pharmacy
Avastin
China

Click the tags to see associated articles and topics

View Article Details
Bio-Thera Solutions Announces FDA Accepts Biologics License Application for BAT2506, a ...

Added to Collection on: 2025-07-16 18:01:32

Tags for this article:

Monoclonal antibodies
Orphan drugs
Immunosuppressants
Disease-modifying antirheumatic drugs
Specialty drugs
Golimumab
Biopharmaceutical
Biosimilar
Adalimumab
Intas Pharmaceuticals
Bevacizumab
Ustekinumab
Bio-Thera Solutions
Thera Solutions, Ltd.
United States

Click the tags to see associated articles and topics

View Article Details
Junshi Biosciences Announces the Acceptance of the sNDA for - GlobeNewswire

Added to Collection on: 2025-08-08 15:38:00

Tags for this article:

Orphan drugs
Antineoplastic drugs
Disitamab vedotin
Antibody-drug conjugate
Bevacizumab
Non-small-cell lung cancer
Toripalimab
Triple-negative breast cancer
Transitional cell carcinoma
Adjuvant therapy
Pembrolizumab
Atezolizumab
Shanghai
China
shanghai junshi biosciences co., ltd.

Click the tags to see associated articles and topics

View Article Details
Biosimilars Market to Surpass US$ 171.79 Billion by 2033 - Exclusive Report by DataM Intelligence

Added to Collection on: 2025-08-22 15:13:23

Tags for this article:

Specialty drugs
Monoclonal antibodies
Orphan drugs
Immunosuppressants
TNF inhibitors
Biosimilar
Biopharmaceutical
Biocon
Adalimumab
Rituximab
Trastuzumab
Bevacizumab

Click the tags to see associated articles and topics

View Article Details
Outlook Therapeutics plunges more than 52% after FDA rejects wet AMD drug

Added to Collection on: 2025-08-28 23:46:55

Tags for this article:

Angiogenesis inhibitors
Orphan drugs
Food and Drug Administration
Bevacizumab
Roche
Aflibercept
Macular degeneration
United States

Click the tags to see associated articles and topics

View Article Details
ANVISA approves ranibizumab and tocilizumab biosimilars

Added to Collection on: 2025-10-03 15:51:43

Tags for this article:

Orphan drugs
Angiogenesis inhibitors
Monoclonal antibodies
Ranibizumab
Biosimilar
Bevacizumab
Vascular endothelial growth factor
Tocilizumab
Macular degeneration
Roche
Anti-VEGF
Aflibercept
Actemra
fresenius kabi

Click the tags to see associated articles and topics

View Article Details
Book a Demo